{"schema_version":"secwatch.filing_event.v1","accession":"0000896622-24-000032","form_type":"8-K","ticker":"ATR","cik":"0000896622","company_name":"APTARGROUP, INC.","filed_at":"2024-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.232040+00:00","generated_at":"2026-05-31T16:33:47.966341+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aptar reports Q2 EPS $1.34 (+8% YoY); raises dividend 10% to $0.45","bullets":["Revenue $910M (+2% reported, +3% core); net income $90M (+9%).","Adjusted EPS $1.37 (+12% YoY) vs. $1.22 prior year; Pharma core sales +7%.","Q3 2024 adjusted EPS guidance range $1.38-$1.46 with tax rate 23.5%-25.5%.","Quarterly dividend raised ~10% to $0.45/share; payable Aug 15, record Jul 25.","Cash from operations $236M YTD (up from $182M); free cash flow $92M."],"urls":{"canonical":"https://secwatch.observer/filing/0000896622-24-000032","json":"https://secwatch.observer/filing/0000896622-24-000032.json","markdown":"https://secwatch.observer/filing/0000896622-24-000032.md","text":"https://secwatch.observer/filing/0000896622-24-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896622/000089662224000032/0000896622-24-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896622/000089662224000032/atr-20240725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:33:47.966341+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}